HPV and Cervical Cancer News

• Shift to HPV Testing Will Require Public Education HPV testing has major advantages over Pap cytology for primary cervical cancer screening. But the effort to change testing procedures is expected to encounter initial resistance.
  Medscape Medical News, May 19, 2022
• Imiquimod Cream Offers Alternative to Surgery for Vulvar Lesions Topical imiquimod offers an alternative to surgery for women with HPV-related precancerous lesions, concludes the first head-to-head randomized trial of the two approaches.
  Medscape Medical News, May 17, 2022
• HPV Strains Covered by the Vaccine Have Declined Greatly in US The study is good news for the HPV vaccination program in the United States.
  Medscape Medical News, May 16, 2022
• Sexual Minorities Less Likely to Receive Pap Screening Sexual minorities who have a cervix are less likely than heterosexual women to be screened for cervical cancer, a new study suggest.
  Reuters Health Information, May 16, 2022
• Imiquimod as Good as Surgery for Vulvar Intraepithelial Neoplasia Topical imiquimod works just as well as surgery for the first-line treatment of women with vulvar high-grade squamous intraepithelial lesions -- a precancerous lesion commonly caused by HPV.
  Reuters Health Information, April 29, 2022
• Oral Probiotic Could Improve HPV Clearance Early evidence suggests an oral probiotic may be an effective strategy to manage HPV. The study was published as a preprint and has not yet been peer reviewed.
  First Look, April 20, 2022
• Cheap and Noninvasive: Detecting HPV in Sanitary Pads HPV can be detected in menstrual pads, and offers hope of a cheap, noninvasive method for cervical screening. So why has no-one in North America heard about it?
  Medscape Medical News, April 19, 2022
• One HPV Vaccine Dose Prevents Cervical Cancer: WHO A single dose of human papillomavirus vaccine is enough to protect against cervical cancer, a World Health Organization group of experts has said.
  Reuters Health Information, April 11, 2022
• Vaginal Estradiol May Benefit Postmenopausal Women Vaginal estradiol tablets promoted significant changes in the vaginal microbiota in postmenopausal women compared with vaginal moisturizer or placebo.
  Medscape Medical News, April 05, 2022
• Broad Drop-Off in Cancer Screenings During Pandemic Many US facilities saw declines in screening rates for colorectal, cervical, breast, and lung cancers during the pandemic, a new study notes.
  Reuters Health Information, March 25, 2022
• Breast, Cervical Screening Suboptimal in Transgender Individuals Transgender individuals were less likely than cisgender individuals to undergo screening for breast and cervical cancer despite their increased risk for these conditions, researchers say.
  Reuters Health Information, March 10, 2022
• ODAC 2022 Combination Treatments a Must for the War on Warts "We can combine destructive, immunologic, and cytotoxic approaches," said Adam Friedman, professor of dermatology at George Washington University, Washington.
  Medscape Medical News, March 08, 2022
• Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence? Performing a routine liquid biopsy test for HPV DNA may allow recurrence of oropharyngeal squamous cell carcinoma to be identified before clinical signs develop, a new study suggests.
  Medscape Medical News, March 02, 2022
• FDA OKs First Condom for Anal Sex Already in stores, the prophylactic can now be marketed as a way to reduce STDs from anal intercourse.
  WebMD Health News, February 25, 2022
• CROI 2022 Full Results of Anal Cancer Study Point to Barriers to Care The results from the landmark trial of preemptive treatment for precancerous anal cells show definitively that treatment should be standard of care. Now comes the hard part.
  Medscape Medical News, February 18, 2022
• AAP Approves CDC's Child/Adolescent Vax Schedule for 2022 The updated schedule contains only minor changes from 2021.
  Medscape Medical News, February 17, 2022
• High-risk HPV Infection Status Predicts Cervical Cancer Mortality A significantly lower excess mortality was observed in high-risk HPV-positive vs high-risk HPV-negative patients.
  Medscape Medical News, February 14, 2022
• Confirmed: Cemiplimab Ups Survival in Recurrent Cervical Cancer Just published data from a phase 3 trial confirm that cemiplimab improves survival in patients with recurrent cervical cancer, as this indication awaits FDA approval.
  Medscape Medical News, February 09, 2022
• COVID Vaccines Open Rifts Between Parents, Children Teenagers, states, and physicians looking for ways to put shots in young arms when parents are vaccine-hesitant.
  Medscape Medical News, February 08, 2022
• Pregnancy Outcomes Improving After Treatment for High-Grade Cervical Neoplasia The risk for pregnancy-related complications following treatment for grade 3 cervical intraepithelial neoplasia (CIN 3) has declined over time, thanks to advances in treatment, a new study indicates.
  Reuters Health Information, February 07, 2022